Asked by: Lord Willoughby de Broke (Non-affiliated - Excepted Hereditary)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what steps they will take to ensure that the five million UK residents who have received the COVID-19 vaccine manufactured in India will be allowed to travel to the EU for business or leisure purposes.
Answered by Lord Bethell
The Government continues to engage with the European Union on certification to ensure that travel between the United Kingdom and the EU is supported by a common approach.
The Serum Institute of India (SII) manufactures Vaxzevria and Covishield and both branded vaccines are the same as the University of Oxford/AstraZeneca vaccine. All SII-made doses approved by the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzeria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria. The European Medicines Agency has authorised Vaxzevria vaccine and it is therefore recognised by the EU.